글로벌 급성 기관지염 시장 – 2029년까지의 산업 동향 및 예측

급성 기관지염 시장 분석 및 규모

글로벌 급성 기관지염 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 전 세계적으로 알레르기 반응이 증가하고 신흥 시장이 이 시장의 성장을 책임지는 요인입니다. 기침 문제를 일으키는 감기와 독감의 증가가 급성 기관지염 시장을 주도합니다. 급성 기관지염의 최대 사례는 바이러스로 인해 발생하며 급성 기관지염의 가장 흔한 증상은 기침입니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 급성 기관지염 시장의 성장률을 분석합니다. 글로벌 급성 기관지염 시장의 예상 CAGR은 언급된 예측 기간 동안 약 4.0%인 경향이 있습니다. 이 시장은 2021년에 40억 달러로 평가되었으며 2029년까지 54억 7천만 달러까지 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

급성 기관지염은 기관과 연결되어 공기를 폐로 운반하는 기관지 염증입니다. 이 염증은 바이러스 또는 박테리아 감염으로 인해 발생할 수 있습니다. 초기 증상은 코와 목에서 기도로 퍼지는 감기 또는 독감입니다. 감염은 2주 동안 지속될 수 있으며 경미한 경우는 집에서 치료할 수 있습니다.

급성 기관지염 시장 범위 및 세분화

Global Acute Bronchitis Market Dynamics

Drivers

• Increasing Prevalence of COPD

Rising prevalence of COPD is a major factor boosting the market growth. As per WHO 2021, COPD is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Thus, it is increasing the demand for acute bronchitis treatment.

• Growing Demand for bronchodilators

The bronchodilator segment is expected to boost the market growth. Bronchodilators are the first-line medication for bronchitis treatment as it helps in clearing airway obstruction, which is an essential parameter in acute bronchitis to ease the breathing process in patients.

Opportunities

• Rising Prevalence of Smoking

Smoking is the leading cause of preventable disease in the U.S., witnessing more than 480,000 deaths yearly, or about 1 in 5 deaths. Currently, cigarette smoking is highest among people aged 25–44 and 45–64. Thus, it creates opportunities for market growth.

• Advanced Clinical Research and Innovative Strategies

Several market players are engaged in the implementation of strategic initiatives, thereby contributing to market growth. For instance, Beta2-agonists was developed because clinicians suspect many patients also have reversible airflow restriction (as seen in asthma or chronic obstructive pulmonary disease (COPD)) contributing to the symptoms.

Restraints/Challenges

• Lack of Awareness

Lack of patient awareness about the disease and differentiated symptoms could curb the growth of the global acute bronchitis market over a forecast period.

• High Cost

The huge expenditure required for treating acute bronchitis surely hamper the market growth.

This global acute bronchitis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global acute bronchitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Acute Bronchitis Market

Considering the present scenario, COVID-19 has left a major global public health crisis impacting every business. Its long-term repercussions are expected to influence industry growth during the forecast period.

The initial phase of the COVID-19 pandemic has led to a reduction in the number of patient visits that reduced the number of patients opting for bronchitis treatment, thereby impacting the market growth. The pandemic has led to an overall reduction in ambulatory adults seeking care for bronchitis in the health system and has resulted in a dramatic reduction in antibiotic prescriptions for this disease.  

Global Acute Bronchitis Market Scope

The global acute bronchitis market is segmented on the basis of type, treatment, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Viral Infection
• Bacterial Infection
• Irritants
• Others

Treatment

• Homecare
• Medication
• Others

Route of Administration

• Oral
• Parenteral Inhalational
• Others

End-Users

• Hospitals
• Specialty Clinics
• Others

Distribution Channel

• Hospitals
• Specialty Clinics
• Others

Acute Bronchitis Market Regional Analysis/Insights

The global acute bronchitis market is analysed and market size insights and trends are provided by type, treatment, route of administration, end-user and distribution channel as referenced above.

The major countries covered in the global acute bronchitis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is the dominating region due to rising infection in children & elderly population, and rising initiatives taken by the pharmaceutical organizations.

Asia-Pacific is likely to hold the largest market share for the acute bronchitis market due to more initiatives taken by the government organizations to spread awareness and immense presence of generic manufacturers. 

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Acute Bronchitis Market Share Analysis

글로벌 급성 기관지염 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 급성 기관지염 시장과 관련된 회사의 초점에만 관련이 있습니다.

세계 급성 기관지염 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Bayer AG(독일)
• Teva Pharmaceutical Industries Ltd. (이스라엘)
• Sun Pharmaceutical Industries Ltd. (인도)
• 히크마제약(미국)
• Amneal Pharmaceuticals LLC. (영국)
• Aurobindo Pharma(인도)
• 존슨앤존슨 서비스 주식회사(미국)
• 글락소스미스클라인 주식회사(미국)

SKU-53518